Suppr超能文献

儿童多动症药物的最新情况。

Update on drugs for hyperactivity in childhood.

出版信息

Drug Ther Bull. 2007 May;45(5):37-40. doi: 10.1136/dtb.2007.45537.

Abstract

In 2001, we concluded that methylphenidate or dexamfetamine can be useful adjunctive therapy for children with severe hyperactivity in whom non-drug approaches alone have been inadequate. Since then, atomoxetine (pronounced a-toe-moks-e-teen; Strattera - Lilly) and three modified-release formulations of methylphenidate have been launched for attention deficit hyperactivity disorder (ADHD). Here we reconsider drugs for ADHD in childhood, focusing on the newer products.

摘要

2001年,我们得出结论,对于仅采用非药物方法治疗效果不佳的重症多动儿童,哌甲酯或右旋苯丙胺可作为有效的辅助治疗药物。自那时起,托莫西汀(发音为a-toe-moks-e-teen;商品名择思达 - 礼来公司生产)以及三种哌甲酯缓释制剂已投放市场用于治疗注意缺陷多动障碍(ADHD)。在此,我们重新审视儿童ADHD的治疗药物,重点关注较新的产品。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验